SCHEMBL27011380

SCHEMBL27011380

c1ccc(-c2ccccc2-c2c3ccccc3c(-c3ccc4c(c3)oc3cccc(-c5ccccc5)c34)c3ccccc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 2/20 0.36
▸ AHR P35869 1/20 0.35
▸ AKR1B1 P15121 2/20 0.35
▸ CA12 O43570 1/20 0.35
▸ ALDH2 P05091 1/20 0.35
▸ MAOA P21397 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ HSD17B3 P37058 1/20 0.35
▸ SORD Q00796 1/20 0.35
▸ CA9 Q16790 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ NTRK1 P04629 1/20 0.34
▸ PLK3 Q9H4B4 1/20 0.34
▸ ALOX5 P09917 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20363688 0.94 HCRTR1 (0.37) HCRTR1AHRAKR1B1CA12ALDH2
SCHEMBL27011259 0.93 HCRTR1 (0.36) HCRTR1AHRAKR1B1CA12ALDH2
SCHEMBL27009966 0.91 PLA2G2A (0.38) HCRTR1AHRAKR1B1CA12ALDH2
SCHEMBL27011320 0.91 PLA2G2A (0.40) HCRTR1AHRAKR1B1CA12ALDH2
SCHEMBL26286839 0.91 PLA2G2A (0.38) HCRTR1AHRAKR1B1CA12ALDH2
SCHEMBL24662701 0.91 AHR (0.38) HCRTR1AHRAKR1B1CA12ALDH2
SCHEMBL23746944 0.91 AHR (0.37) HCRTR1AHRCA12MAOACA9
SCHEMBL27011442 0.91 PSD (0.38) HCRTR1AHRCA12MAOBCA9
SCHEMBL23427215 0.90 CDC14B (0.34) HCRTR1AHRAKR1B1CA12ALDH2
SCHEMBL25575653 0.90 CDC14B (0.34) HCRTR1AHRAKR1B1CA12ALDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EED, EML4, ESR1 HCRTR1 3958/4885AHR 1866/4885AKR1B1 4226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback